Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Former FDA Chief Counsel Stacy Cline Amin Joins Morrison & Foerster's Leading Life Sciences + Healthcare Practice in Washington, D.C.; Will Co-Lead FDA Regulatory and Compliance Practice

The arrival of Stacy Cline Amin, former FDA Chief Counsel, further deepens the firm's market-leading life sciences and healthcare capabilities; fifth senior government official to join the Washington, D.C. office since the start of 2021.


News provided by

Morrison & Foerster

Jun 22, 2021, 09:30 ET

Share this article

Share toX

Share this article

Share toX

WASHINGTON, June 22, 2021 /PRNewswire-PRWeb/ -- Morrison & Foerster, a leading global law firm, is pleased to announce the arrival of Stacy Cline Amin as a partner in its Life Sciences + Healthcare practice. Ms. Amin will be based in Washington, D.C. and will co-lead the FDA Regulatory and Compliance practice. She joins Morrison & Foerster after a decade serving at the highest levels of government, where she most recently served in a dual role as Chief Counsel of the Food and Drug Administration and Deputy General Counsel of the U.S. Department of Health and Human Services.

In this senior advisory role, Ms. Amin led the FDA's Office of the Chief Counsel and served as a trusted strategist and advisor to the FDA Commissioner, the Center Directors and other FDA leaders, and the Secretary of HHS. She played a critical role in nearly every aspect of the FDA's COVID-19 pandemic response effort, including record numbers of emergency use authorizations, guidances, and enforcement actions, and served as one of the key leaders of the teams that issued the first two COVID-19 vaccine authorizations. During her two-and-a-half year tenure at the FDA, Ms. Amin navigated difficult regulatory issues and litigation challenges across the agency's entire portfolio, including civil and criminal enforcement matters, human gene therapy and regenerative medicine, in vitro diagnostics, medical device safety and innovation, digital health, animal and plant biotech, and food safety modernization.

Prior to Ms. Amin's role as FDA Chief Counsel, she served in the White House Counsel's Office as a Senior Associate Counsel to the President, as the Chief Counsel of the Senate Health, Education, Labor & Pensions Committee, and as a Counsel on the House Energy & Commerce Committee. In these roles, she helped steer landmark legislation and regulatory change, with a focus on FDA, precision medicine, and digital health, and led high-stakes government investigations. Ms. Amin's oversight efforts supported a number of legislative accomplishments, including passage of the Drug Quality and Security Act of 2013, the Cybersecurity Act of 2015, and the 21st Century Cures Act of 2016.

"Stacy brings exceptional healthcare and life sciences experience to the firm, having served in senior level positions in FDA, HHS, and the Executive and Legislative branches," said Morrison & Foerster Chair Larren M. Nashelsky. "Her highly strategic regulatory and healthcare enforcement experience adds significant depth and breadth to our life sciences, healthcare, and FDA practices. Most recently, she played a key role in establishing the guidelines the FDA followed to ensure scientists could conduct independent, science-based reviews of the safety and efficacy of COVID-19 vaccines, and in managing the exceptionally complex legal issues in the face of this unprecedented global pandemic. Stacy will be an invaluable addition to our COVID-19 Task Force."

Morrison & Foerster Global Litigation Department co-chair Bradley D. Wine added: "We are excited to have Stacy join our FDA Regulatory and Compliance practice, enhancing our ability to offer unparalleled FDA regulatory, investigations, litigation, and enforcement counseling to our clients, making Morrison & Foerster a best-in-class destination for clients navigating complex and mission-critical issues before the FDA."

Michael Ward, Global Head of Morrison & Foerster's Life Sciences + Healthcare practice, said: "Now could not be a better time for Stacy to join our dynamic, global Life Sciences + Healthcare practice to co-lead our FDA practice with Bethany Hills. Stacy brings an impressive breadth of expertise in life sciences and healthcare legal and regulatory issues that will serve our clients in major life sciences hubs around the world, such as San Francisco, Boston, San Diego, Tokyo, and Berlin."

Ms. Amin's arrival also highlights the continued expansion of the firm's Washington, D.C. office and its litigation and regulatory capabilities. Since the start of 2021, the firm has added five former senior government officials as partners in Washington, D.C., including Ms. Amin, Brian Kidd, Brandon Van Grack, Alexander Okuliar, and David Shaw.

"After having spent a career serving across all branches of the U.S. Government, I'm excited to help clients in the life sciences and healthcare industries navigate their most difficult regulatory, compliance, and litigation challenges," said Ms. Amin. "Morrison & Foerster's unparalleled expertise at the intersection of health, life sciences, and technology and its commitment to exceptional client service is what attracted me to the firm. Together with my colleagues in the Life Sciences + Healthcare practice, I look forward to supporting our clients achieve their goals and improve the lives of people everywhere."

Ms. Amin earned her B.A., summa cum laude, from George Washington University, and her J.D., cum laude, from Harvard Law School. Following law school, she clerked for the Hon. John R. Gibson in the U.S. Court of Appeals for the Eighth Circuit. Ms. Amin is admitted to the D.C. bar.

ABOUT MOFO

We are Morrison & Foerster—a global firm of exceptional credentials. Our clients include some of the largest financial institutions, investment banks, and Fortune 100, technology, and life sciences companies. Highlighting the firm's commitment to client service and leadership in market-changing deals and impact litigation, MoFo was recognized as one of the top 15 firms on The American Lawyer's 2020 A-List. Year after year, the firm receives significant recognition from Chambers and The Legal 500 across their various guides, including Global, USA, Asia-Pacific, Europe, UK, Latin America, and FinTech Legal. Our lawyers are committed to achieving innovative and business-minded results for our clients, while preserving the differences that make us stronger. The firm also has a long history of commitment to the community through providing pro bono legal services, including litigating for civil rights and civil liberties, improving public education for poor children, advocating for veterans, promoting international human rights, winning asylum for the persecuted, and safeguarding the environment.

Media Contact

Marie Armstrong-Hebert, Morrison & Foerster, +44 0 20 7920 4065, [email protected]

SOURCE Morrison & Foerster

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.